Hypertension is a modifiable risk factor for cardiovascular disease, but its aetiology has not been fully elucidated. Recently, attention has been focused on the direct relations of plasma homocysteine (Hcy) to blood pressure (BP). The purpose of this study was to determine the relationship of Hcy with BP and other cardiovascular disease risk factors. This populationbased study was a part of the Cardiovascular Risk Factors Survey and has been designed and conducted based on the methodology of the MONICA/WHO Project. A total of 1214 people aged 25-64 years were recruited using cluster sampling and assessed regarding standardized methods. BP was measured in seated position after a 10-min rest period. Blood samples were gathered and analysed according to standard methods. Variables were assessed in 1191 participants (416 men; 775 women). Mean age was higher in hypertensives compared to normotensives (Po0.001). Mean Hcy was higher in hypertensives, but significant only in men (Po0.031). Concurrent effects of Hcy, folate and vitamin B 12 on hypertension indicated that Hcy acts as a risk factor and folate and vitamin B 12 as protective factors; however, after adjustment, just vitamin B 12 remained as a protective factor. Although we detected a simple correlation of Hcy with BP in Iranian adults, this relationship was no longer significant after applying an adjustment. In light of our observations, it is likelyIntroduction Cardiovascular disease is a major cause of morbidity and mortality worldwide. 1 Elevated blood pressure (BP) is an important modifiable risk factor for cardiovascular disease. Although its aetiology has not been fully elucidated mostly because of as yet unknown genetic variations, multiple nonhereditary factors including dietary and other lifestyle factors have been identified that have important and modifiable influences on BP. 2 Nutritional advice for the control and prevention of hypertension is already substantial, 3 but additional understanding of the causal role of nutritional factors is important given the high prevalence of elevated BP. 4 Recently, attention has been focused on the direct relations of plasma homocysteine (Hcy) to BP and hypertension [4] [5] [6] [7] because of the suggestion that the adverse risk associated with hyperhomocysteinaemia (HHcy) might be mediated in part by the positive association of Hcy with hypertension. 8 Hcy is an intermediate sulphur-containing amino acid formed during the intracellular metabolism of methionine, an essential amino acid supplied by dietary proteins. 9 Elevated plasma Hcy concentration is considered a risk factor for cardiovascular disease and may also be associated with hypertension. 10 Some reports describe a significant relationship between Hcy and BP levels, as well as higher Hcy in hypertensives compared to normotensives, 10 and also the vascular risk associated with HHcy has been observed to be stronger in hypertensive individuals.
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Hcy may elevate BP through multiple mechanisms, including its effect on vascular endothelial integrity. Hcy administration caused direct endothelial cell injury in vitro 12 and in animals. 13 In cell culture studies, Hcy induced oxidative stress to endothelium 14 and reduced available nitric oxide, a potent vasodilator. 15 Confirming these observations in humans, endothelium-dependent vasodilatation was impaired in temporary 16, 17 or chronic 18, 19 HHcy. Plasma Hcy levels are determined by both genetic 20 and nutritional factors. Folate, and vitamin B 12 are the major nutritional determinants of Hcy levels, 21 and have a protective association with cardiovascular disease. [22] [23] [24] The protective effect of these B vitamins may be partly explained by mechanisms independent of Hcy, as suggested by several recent studies, 25 and the B vitamins may themselves affect BP. 26, 27 Observations that Hcylowering therapies with folic acid-based treatments have been followed by decreases in BP raise the possibility that the link between Hcy and BP is causal, which is important since Hcy levels can easily be lowered by folic acid-based regimens. 28 The purpose of this study was to determine the relationship of Hcy with BP, and other cardiovascular disease risk factors, including body mass index (BMI), glucose, lipids and smoking status on the one hand and between Hcy nutritional determinants and hypertension in a healthy adult Iranian population as part of the 'Tehran Homocysteine Survey' on the other hand (Table 1) . This observation may have substantial public health implications and may induce preventive public implementations such as fortification with folic acid in our country.
Materials and methods

Study design
The present data are part of a cross-sectional study ( 
Subjects and study criteria
Totally, 1214 healthy participants (428 men and 786 women) aged 25-64 years were recruited for this part of the study. Individuals who were not interested to take part or did not meet the inclusion criteria (being healthy and 25-64 years old), or had incomplete data, were excluded. Therefore, our analyses are based on 1191 participants (416 men and 775 women) with complete data on plasma total Hcy, folate, vitamin B 12 , lipids and glucose concentrations. Exclusion criteria included known coronary heart disease (CHD), systemic illness, serious organ disease, proliferative and endocrine diseases, alcoholism, current pregnancy, current use of vitamins or other supplements, anticonvulsant and anticancer therapy. Participants with known hypertension and who were taking antihypertensive medications were not withdrawn from their medication. All subjects underwent a standardized medical history, physical examination, anthropometric measurements and laboratory tests. Personal and lifestyle information were obtained by using modified MONICA questionnaires. 30 Height and weight were obtained, and BMI was calculated. BP was measured in the seated position, in the right arm supported at the level of the heart, by using a standard mercury column sphygmomanometer, suitable cuff size and the auscultation of the Korotkoff phenomena. Standard conditions were maintained; that is, the same nurse measured BP after at least a 10-min rest period, at the same time of the day. Participants had not consumed caffeine for at least 1 h and had not smoked for preceding 15 min. They were sitting with their back supported in a quiet and temperate place. The average of two determinants of systolic (first phase) and diastolic (fifth phase) were used as systolic and diastolic BP, respectively (SBP and DBP). All respondents gave their written informed consent. Our research protocol was approved by the EMRC ethics committee and conformed to the principles embodied in the declaration of Helsinki. What is known about this topic?
K Several studies have investigated these variables and their relationship worldwide. K Some detected a positive relationship between Hcy, its determinants and BP and other cardiovascular riskfactors, but others did not.
What this study adds?
K This study is the first population based study which investigated the relation of Hcy and its determinants with BP and other cardiovascular risk factors in Iran. K In case our study detects a positive relationship, the health authorities would be able to diminish the risk of CAD by manipulating the determinants of Hcy. K This study also evaluates the relation of folate and vitamin B 12 (the nutritional determinants of Hcy which influence the risk of CAD) with BP and other cardiovascular risk factors. K This study assesses the status of these B vitamins in Iranian population, so that the health authorities would be able to decide about benefits of grain fortification in order to prevent vitamin deficiencies and related diseases consequently.
Laboratory analyses
Fasting blood samples were obtained in the early morning hours after a 12 h fast. The plasma samples were put in a cooled container and immediately carried to the EMRC laboratory, where the plasma was separated within 2 h of sampling by centrifugation (20 min, RT, at 2000 RPM), and aliquots were stored at À701C until determinations. In this part of the study, the following parameters were analysed: total plasma Hcy, serum vitamin B 12 , folate, lipids and glucose. Plasma total Hcy concentrations were determined on frozen samples by High-performance Liquid Chromatography (HPLC) method (KNAUER, Germany), coupled with a fluorescence detector. The method has been validated over a linearity range of 1-100 mmol/l from plasma. The intra-assay and inter-assay coefficients of variation for Hcy samples were 3.9 and 5.8%, respectively. Folate and vitamin B 12 were measured simultaneously in the frozen serum aliquot by a double labelled radioimmunoassay (ICN Pharmaceuticals, NY, USA). The intra-assay coefficient of variation for folate and vitamin B 12 were 6.9 and 6.1% respectively. The inter-assay coefficients of variation for folate and vitamin B 12 were 7.5 and 6.8%, respectively. Serum total cholesterol, HDL cholesterol and total triglycerides were analysed with standard enzymatic methods (Pars Azmun, Iran). LDL cholesterol was calculated by the Friedewald equation; 31 however, samples with triglycerides 4400 mg/dl were analysed with standard enzymatic methods (Pars Azmun, Iran). Plasma glucose concentration was analysed with the glucose oxidase technique (Pars Azmun, Iran).
Data analyses
Participants were stratified by sex and classified according to BP status as normotensive or hypertensive (SBP X140 mmHg and/or DBP X90 mmHg or if the participant was taking antihypertensives). 32 We also considered total Hcy ¼ 10-30 mmol/l and 30-100 mmol/l as mild and moderate HHcy, respectively. 33, 34 Diabetes was defined according to the current American Diabetes Association guidelines. 35 Mean BP was calculated with (SBP þ 2 DBP)/3 and pulse BP with SBP minus DBP formula. Other normal values were defined as FBS o126 mg/dl, cholesterol o200 mg/dl, TG o200 mg/dl, LDL o200 mg/dl and HDLX40 mg/dl.
The distributions of total Hcy, folate and vitamin B 12 concentrations were skewed to the right; therefore, values were logarithmically transformed (Ln) and presented as geometric mean and 95% confidence intervals (CI). 
Results
'The Tehran Homocysteine Survey' data on 1214 adults (428 men and 786 women) 36 with Hcy and BP measurement comprised the study sample. A total of 23 persons were excluded because of incomplete data on BP, or not meeting inclusion criteria, yielding 1191 (416 men and 775 women) individuals for study. The baseline characteristics of our study participants are displayed in Table 2 . Table 3 provides the sex-specific mean values of age, BMI, Hcy, folate, vitamin B 12 , FBS, and serum lipids for hypertensives and normotensives. Mean age was higher in hypertensives compared to normotensives in both men and women (Po0.001).
Within each gender, the geometric mean Hcy was higher in the hypertensives compared to the normotensives; however, this difference was statistically significant only in men (Po0.031); in women it was of borderline significance (Po0.067). There was no significant difference in serum folate or vitamin B 12 between normotensives and hypertensives.
The Hcy concentration was also compared between smokers (n ¼ 163) and nonsmokers (n ¼ 948). Among both men and women, there was a significant difference in geometric mean Hcy between smokers (males: 20.44 mmol/l71.45; females: 16.34 mmol/ l71.53) and nonsmokers (males: 18.56 mmol/ l71.45; females: 13.9 mmol/l71.45) (In both genders: Po0.01).
To further examine the effect of Hcy levels on both SBP and DBP, the sex-specific correlation coefficients of Hcy with the other parameters as continuous variables were examined in regression models (Table 4). In women, Hcy was significantly correlated with SBP (crude r ¼ 0.142, Po0.0001) and DBP (crude r ¼ 0.107, Po0.003). There was a significant correlation in their male counterparts between DBP (crude r ¼ 0.123, Po0.012) but not SBP (crude r ¼ 0.087, Po0.076). In women, when BMI and age were added as cofactors, the effect of Hcy on SBP was statistically (Table 5) .
Hcy was positively associated with age, male sex and current smoking. There was little or no association of Hcy with BMI, total cholesterol, HDL, LDL, TG and FBS when the variables were adjusted according to age and BMI (data are not shown).
Discussion
Hypertension is one of the leading causes of premature cardiovascular morbidity and mortality. The aetiology of hypertension is complex due to the interaction of hereditary and environmental factors. 37 Elevated Hcy, even mild HHcy is a major risk factor for arterial vascular disease, 38 independent of conventional risk factors, such as diabetes mellitus, cigarette smoking, or hyperlipidemia.
Numerous studies showed a strong association between elevated Hcy and CAD. 39, 40 Several studies also showed a significant association between Hcy and BP, [4] [5] [6] [41] [42] [43] [44] [45] or HTN; 1,46 however, no association was found in other studies 47, 48 (Table 6) . Recently, a randomized, placebo-controlled, Hcy-lowering trial reported a decrease in BP in response to treatment. 49 Kahleova et al 42 reported higher Hcy in adolescents and young adults with hypertension compared to age-matched normotensives. Similar findings concerning the relationship between plasma Hcy and BP were provided by the SHEP study (Systolic Hypertension in the Elderly Program), which showed a direct correlation between fasting plasma Hcy and SBP. 46 In the NHANES III investigation, 4 Hcy had an independent positive association with BP after adjusting for cardiovascular risk factors, and was stronger in women than in men.
The Hordaland Hcy study 5 examined a very large sample (16, 176 individuals) and reported a weak association of plasma Hcy with SBP and DBP that was confined to younger individuals (those aged 40-42 years), but was not significantly associated with BP in a sub-group aged 65-74 years. Similarly, in data from the UK National Diet and Nutrition Survey, tHcy was only weakly associated with BP. 50 Dalery et al 51 determined plasma levels of Hcy in 584 healthy subjects and in 150 subjects with coronary artery disease (CAD) (ageo60 years); no significant correlation was found between plasma Hcy levels and the presence of HTN in both groups. Brattstrom et al 52 showed that plasma Hcy values were unrelated to the presence of HTN in a group of stroke survivors.
The Framingham Heart Study 8 investigated for the first time in a community-based setting the relations No association between either SBP or DBP and Hcy concentration was found in subjects without antihypertensive medications. However, the concentrations of folate and B 12 for the hypertensive subjects were generally higher than for the controls. This study did not discover that the elevation of Hcy levels was an independent risk factor for essential HTN in a Chinese population. In addition, Virdis et al 54 did not find any association between Hcy and SBP and DBP.
In our study, data on a sample of 25-64-year-old apparently healthy Iranian adults primarily demonstrate a correlation of Hcy with HTN that is significant in men. Although we detected a significant simple correlation coefficient of Hcy with BP, this relationship was no longer significant after applying an adjustment for age and BMI in the analysis, so we failed to reveal any significant correlation between plasma Hcy levels and SBP or DBP. There were no cases of severe homocysteinemia in our sample of Iranian adults; however 1002 (82.5%) and 66 (5.4%) cases had mild and moderate HHcy, respectively. 36 We observed that the relations of plasma Hcy to BP outcomes were attenuated by adjustment for age. Because age is an important determinant of plasma Hcy, 6 it is possible that plasma Hcy is a marker for age and age-related mild, subclinical renal dysfunction. 55 In most previous cross-sectional studies, antihypertensive medication use has been a stronger correlate of plasma Hcy than BP levels. 4, 6, 42 Some hypertensive drugs might have Hcy-elevating effects, 56 which might have contributed to previously observed associations, but we did not observe a considerable difference in tHcy between hypertensives who were medicated by antihypertensive drugs and who were not.
We also found that the correlation of folate and vitamin B 12 with Hcy in women and men was all negative, indicating an inverse relationship of Hcy with folic acid and vitamin B 12 . These results suggest that the potential contribution of folate, perhaps mediated by Hcy and BP, if causal, would mean that Hcy lowering leads to reduced BP with attendant public health benefits; 2 but after adjustment for age, gender, BMI and smoking, we observed that only vitamin B 12 remained as a protective factor for HTN.
Experimental evidence suggests that HHcy can be considered as a risk factor for cardiovascular disease because of its prothrombic and proatherosclerotic effects. Although several case-control and crosssectional studies indicate that HHcy has a direct relationship with atherosclerotic lesions and cardiovascular events, such a relationship seems not to be supported by prospective studies, yet. Moreover, at the present time there are no data from prospective controlled studies showing that HHcy precedes atherosclerotic lesions and that reduction in plasma Hcy can reduce the risk of cardiovascular events. On the possible interaction between HHcy and HTN and the occurrence of cardiovascular events, available data from nonprospective studies are scanty and inconclusive. Therefore, this possibility needs to be assessed by prospective controlled studies. For these reasons, the Prevention Conference V by the American Heart Association 57 included Hcy among conditional risk factors, considering as 'conditional' those risk factors whose quantitative relation to major coronary events remains to be defined in large controlled prospective studies.
Our data demonstrate the expected inverse relationship between Hcy and the B vitamins, folate and B 12 which are cofactors in methionine metabolism. The Dietery Approach to Stop Hypertension (DASH) study 58 demonstrated the BP reduction effect of a diet that was high in multiple nutrients achieved by high intakes of fruits, vegetables and low fat dairy foods. It is possible that the association of higher BP with higher Hcy that was detected in our sample of Iranian adults was a consequence of lower dietary intakes of vitamins critical in Hcy metabolism as well as other nutrients that have a beneficial effect on BP.
Several factors that might influence plasma Hcy levels were not assessed in our investigation, such as intake of caffeine and alcohol. 6 In light of our observations, it is likely that the increased plasma Hcy levels previously reported in hypertensive persons are concomitant rather than a precursor of hypertension. 55, 59 In conclusion, our data do not demonstrate an independent effect of plasma Hcy on BP in Iranian adults. The relationship of Hcy with BP that cosegregates with the effect of BMI (or sex), along with a detectable effect of smoking on Hcy levels, indicates that Iranian adults could benefit from lifestyle changes. Data from this study support the potential benefit of efforts to improve dietary intake of multiple nutrients along with smoking cessation as preventive measures in high-risk patients.
